This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.
Alumni | RSS | AA | Languages
 

RSS Feeds

RSS Feed - Life Sciences - Transactions - Kaye Scholer LLP

Current Feed: http://www.kayescholer.com/practice/rss.xml?p=life_sciences_transactions

> Change Feed

Kaye Scholer Advises Sandoz in Commercialization Agreement with Anacor Pharmaceuticals (07/21/14)

Kaye Scholer Advises Shareholders in €130M Sale of Activaero GmbH to Vectura Group (07/17/14)

Kaye Scholer Represents Pfizer in Acquisition of InnoPharma (07/16/14)

Dr. Gottfried Freier (07/09/14)

Dr. Gottfried Freier is Special Counsel at Kaye Scholer and headed the Frankfurt office as its Managing Partner from 2007 to May 2012. Prior to going into private practice, Gottfried was in-house counsel with BASF Aktiengesellschaft in the Patent, Central Legal and Group Tax Departments, and later became General Counsel of BASF Pharma, with worldwide responsibility for legal, taxes, insurance and trademarks. 

Kaye Scholer Advises on Sale of Pharmalink Consulting to Genpact (07/08/14)

Kaye Scholer Honored With 14 Practice and 48 Lawyer Rankings in Chambers USA 2013 (07/07/14)

Sandoz to Acquire Fougera Pharmaceuticals for $1.5B (06/13/14)

Kaye Scholer Advises Pfizer in Exclusive Worldwide Licensing Agreement with Gliknik (06/13/14)

Andres Liivak (06/06/14)

Andres Liivak is the Co-Chair of Kaye Scholer’s Life Sciences Industry Group and a Partner in the firm’s Corporate Department. Working together with the firm’s highly regarded, collaborative, multidisciplinary life sciences team, Andres helps life sciences healthcare industry clients develop comprehensive solutions and manage risk to achieve their business objectives. In his practice, Andres focuses on putting in place new deals as well as counseling with respect to and renegotiating existing transactions, including:

  • Priority, high value deals – examples include in-licenses of blockbuster drugs; acquisitions of target companies and products, including with sales force; divestures of approved products together with supply chain transition; collaborative development and commercialization license arrangements; contentious renegotiation of major commercial contracts relating to key products; and settlement of major IP and contract litigation with business deals.
  • Deals outside a client's comfort zone or recent experience – examples include co-promotion arrangements and companion diagnostic deals.
  • Unusually complex, novel deals – some recent examples include multi-party, multi-product collaborations involving co-development, co-commercialization and exclusive supply arrangements.

Sydney E. Unger (05/29/14)

Sydney Unger is the former Chair of the Tax Department. He practices in the area of tax law with a concentration in renewable energy, corporate and joint venture matters. He has considerable experience in working with clients in renewable energy project financing, mergers and acquisitions, corporate restructuring and bankruptcy workouts, leveraged leasing transactions and IRS and New York controversy matters.

Subscribe

 
 
Practice Practice Groups Industry Groups Regional Groups Pro Bono Professionals Firm Careers Diversity Pro Bono Newsroom Events Offices